Table of Content

1 Nuclear Medicine/Radiopharmaceutic Market Introduction and Overview
1.1 Nuclear Medicine/Radiopharmaceutic Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Manufacturer
2.2 Manufacturers Nuclear Medicine/Radiopharmaceutic Production Sites, Area Served, Product Types
2.3 Nuclear Medicine/Radiopharmaceutic Market Competitive Situation and Trends
2.3.1 Nuclear Medicine/Radiopharmaceutic Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Bracco Imaging
3.1.1 Bracco Imaging Company Profile
3.1.2 Nuclear Medicine/Radiopharmaceutic Product Overview
3.1.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
3.1.4 Bracco Imaging Business Overview
3.2 Bayer
3.2.1 Bayer Company Profile
3.2.2 Nuclear Medicine/Radiopharmaceutic Product Overview
3.2.3 Bayer Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
3.2.4 Bayer Business Overview
3.3 Mallinckrodt
3.3.1 Mallinckrodt Company Profile
3.3.2 Nuclear Medicine/Radiopharmaceutic Product Overview
3.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
3.3.4 Mallinckrodt Business Overview
3.4 Nordion
3.4.1 Nordion Company Profile
3.4.2 Nuclear Medicine/Radiopharmaceutic Product Overview
3.4.3 Nordion Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
3.4.4 Nordion Business Overview
3.5 Triad Isotopes
3.5.1 Triad Isotopes Company Profile
3.5.2 Nuclear Medicine/Radiopharmaceutic Product Overview
3.5.3 Triad Isotopes Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
3.5.4 Triad Isotopes Business Overview
3.6 Lantheus
3.6.1 Lantheus Company Profile
3.6.2 Nuclear Medicine/Radiopharmaceutic Product Overview
3.6.3 Lantheus Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
3.6.4 Lantheus Business Overview
3.7 IBA Group
3.7.1 IBA Group Company Profile
3.7.2 Nuclear Medicine/Radiopharmaceutic Product Overview
3.7.3 IBA Group Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
3.7.4 IBA Group Business Overview
3.8 GE Healthcare
3.8.1 GE Healthcare Company Profile
3.8.2 Nuclear Medicine/Radiopharmaceutic Product Overview
3.8.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
3.8.4 GE Healthcare Business Overview
3.9 China Isotope & Radiation
3.9.1 China Isotope & Radiation Company Profile
3.9.2 Nuclear Medicine/Radiopharmaceutic Product Overview
3.9.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
3.9.4 China Isotope & Radiation Business Overview
3.10 Jubilant Pharma
3.10.1 Jubilant Pharma Company Profile
3.10.2 Nuclear Medicine/Radiopharmaceutic Product Overview
3.10.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
3.10.4 Jubilant Pharma Business Overview
3.11 Eli Lilly
3.11.1 Eli Lilly Company Profile
3.11.2 Nuclear Medicine/Radiopharmaceutic Product Overview
3.11.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
3.11.4 Eli Lilly Business Overview
4 Global Nuclear Medicine/Radiopharmaceutic Historical and Forecast Market Analysis by Type
4.1 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Type
4.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Forecast by Type (2024-2030)
5 Global Nuclear Medicine/Radiopharmaceutic Historical and Forecast Market Analysis by Application
5.1 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application (2019-2024)
5.2 Nuclear Medicine/Radiopharmaceutic Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Nuclear Medicine/Radiopharmaceutic Market Size & Forecast (2019-2030)
6.2 Nuclear Medicine/Radiopharmaceutic Growth Trends Analysis by Regions
6.2.1 Nuclear Medicine/Radiopharmaceutic Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Nuclear Medicine/Radiopharmaceutic Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Nuclear Medicine/Radiopharmaceutic Forecasted Revenue Market Size by Regions (2024-2030)
6.2.4 North America Nuclear Medicine/Radiopharmaceutic Market Size & Forecast (2019-2030)
6.2.5 Europe Nuclear Medicine/Radiopharmaceutic Market Size & Forecast (2019-2030)
6.2.6 China Nuclear Medicine/Radiopharmaceutic Market Size & Forecast (2019-2030)
6.2.7 Japan Nuclear Medicine/Radiopharmaceutic Market Size & Forecast (2019-2030)
6.2.8 Korea Nuclear Medicine/Radiopharmaceutic Market Size & Forecast (2019-2030)
6.2.9 Southeast Asia Nuclear Medicine/Radiopharmaceutic Market Size & Forecast (2019-2030)
6.2.10 India Nuclear Medicine/Radiopharmaceutic Market Size & Forecast (2019-2030)
6.2.11 South America Nuclear Medicine/Radiopharmaceutic Market Size & Forecast (2019-2030)
6.2.12 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Market Size & Forecast (2019-2030)
7 North America
7.1 North America Nuclear Medicine/Radiopharmaceutic Revenue by Players
7.2 North America Nuclear Medicine/Radiopharmaceutic Revenue by Types
7.3 North America Nuclear Medicine/Radiopharmaceutic Revenue by Applications
7.4 North America Nuclear Medicine/Radiopharmaceutic Revenue, Gross and Gross Margin (2019-2024)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Players
8.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Types
8.3 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Applications
8.4 Europe Nuclear Medicine/Radiopharmaceutic Revenue, Gross and Gross Margin (2019-2024)
8.5 Europe PEST Analysis
9 China
9.1 China Nuclear Medicine/Radiopharmaceutic Revenue by Players
9.2 China Nuclear Medicine/Radiopharmaceutic Revenue by Types
9.3 China Nuclear Medicine/Radiopharmaceutic Revenue by Applications
9.4 China Nuclear Medicine/Radiopharmaceutic Revenue, Gross and Gross Margin (2019-2024)
9.5 China PEST Analysis
10 Japan
10.1 Japan Nuclear Medicine/Radiopharmaceutic Revenue by Players
10.2 Japan Nuclear Medicine/Radiopharmaceutic Revenue by Types
10.3 Japan Nuclear Medicine/Radiopharmaceutic Revenue by Applications
10.4 Japan Nuclear Medicine/Radiopharmaceutic Revenue, Gross and Gross Margin (2019-2024)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Nuclear Medicine/Radiopharmaceutic Revenue by Players
11.2 Korea Nuclear Medicine/Radiopharmaceutic Revenue by Types
11.3 Korea Nuclear Medicine/Radiopharmaceutic Revenue by Applications
11.4 Korea Nuclear Medicine/Radiopharmaceutic Revenue, Gross and Gross Margin (2019-2024)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue by Players
12.2 Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue by Types
12.3 Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue by Applications
12.4 Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue, Gross and Gross Margin (2019-2024)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Nuclear Medicine/Radiopharmaceutic Revenue by Players
13.2 India Nuclear Medicine/Radiopharmaceutic Revenue by Types
13.3 India Nuclear Medicine/Radiopharmaceutic Revenue by Applications
13.4 India Nuclear Medicine/Radiopharmaceutic Revenue, Gross and Gross Margin (2019-2024)
13.5 India PEST Analysis
14 South America
14.1 South America Nuclear Medicine/Radiopharmaceutic Revenue by Players
14.2 South America Nuclear Medicine/Radiopharmaceutic Revenue by Types
14.3 South America Nuclear Medicine/Radiopharmaceutic Revenue by Applications
14.4 South America Nuclear Medicine/Radiopharmaceutic Revenue, Gross and Gross Margin (2019-2024)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue by Players
15.2 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue by Types
15.3 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue by Applications
15.4 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue, Gross and Gross Margin (2019-2024)
15.5 Middle East & Africa PEST Analysis
16 Nuclear Medicine/Radiopharmaceutic Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
17 Nuclear Medicine/Radiopharmaceutic Industry Dynamic Analysis
17.1 Nuclear Medicine/Radiopharmaceutic Market Trends Analysis
17.2 Nuclear Medicine/Radiopharmaceutic Market Drivers Analysis
17.3 Nuclear Medicine/Radiopharmaceutic Market Challenges Analysis
17.4 Nuclear Medicine/Radiopharmaceutic Market Restraints Analysis
18 Research Findings and Conclusion